USPTO Examiner RUDDIE ELLIOT S - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18937637Portable Child Anti-choking First Aid EquipmentNovember 2024March 2025Allow400YesNo
18603017DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERYMarch 2024January 2025Allow1000NoNo
18439843SYSTEM AND METHOD FOR CONTROLLING AND MONITORING FLOW IN AN ENDOTRACHEAL TUBEFebruary 2024May 2025Allow1511NoNo
18389897DEVICES, SYSTEMS, AND METHODS FOR PROVIDING INDIVIDUALIZED DELIVERY OF SUSPENDED MEDICATIONDecember 2023December 2024Allow1220YesNo
18541371Inhalers and Related MethodsDecember 2023January 2025Allow1300YesNo
18541605Venturi Inhalation DeviceDecember 2023May 2025Abandon1710NoNo
18541997Venturi Inhalation DeviceDecember 2023May 2025Abandon1710NoNo
18515604MODULAR ELBOW FRAME ASSEMBLY FOR A VENTILATORNovember 2023December 2024Allow1321YesNo
18512906SMART VALVED HOLDING CHAMBERNovember 2023June 2025Allow1910NoNo
18509316HIGHLY PORTABLE GAS DELIVERY SYSTEMSNovember 2023June 2024Allow710YesNo
18386028Biometric and environmental monitoring and control systemNovember 2023January 2025Allow1510NoNo
18448477SENSING FOR RESPIRATORY CIRCUITSAugust 2023November 2024Allow1500NoNo
18350097OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICEJuly 2023January 2025Allow1820YesNo
18330040DETECTION AND MONITORING OF DOSAGE DELIVERY FOR VAPORIZED WAXES, SOLIDS OR VISCOUS OILS, AND CANNABINOIDSJune 2023June 2025Allow2410NoNo
18315437APPARATUS AND METHOD FOR PROVIDING GASES TO A USERMay 2023May 2025Allow2400NoNo
18195457ENDOTRACHEAL TUBE GUARD WITH OPTIONAL HOLDING SYSTEM AND OPTIONAL SENSORMay 2023September 2024Allow1710NoNo
18309963DISPENSING DEVICE AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RHINITISMay 2023April 2025Allow2300NoNo
18140846Biometric and Environmental Monitoring and Control SystemApril 2023September 2024Allow1700YesNo
18131165MOUTHPIECE WITH FLAVORED ATTACHMENTApril 2023November 2024Allow1900YesNo
18128959BREATH INDICATORMarch 2023June 2025Allow2630YesNo
18117823DRY POWDER DRUG DELIVERY SYSTEM AND METHODSMarch 2023July 2024Allow1710NoNo
18173994PATIENT MONITORING APPARATUS AND METHODFebruary 2023February 2024Allow1110NoNo
18100836INTEGRATING ACOUSTIC RESONANCE WITH SLEEP APNEA THERAPYJanuary 2023July 2024Abandon1820NoNo
18156429METERED DOSE INHALER ADD-ON DEVICE, OBSERVANCE IMPROVEMENT SYSTEM AND METHOD FOR IMPROVING OBSERVANCE OF USE IN METERED DOSE INHALERSJanuary 2023March 2024Allow1400YesNo
18146298ASYMMETRICAL NASAL DELIVERY ELEMENTS AND FITTINGS FOR NASAL INTERFACESDecember 2022April 2025Allow2820NoNo
18083986Ventilator Adapter and Auxiliary Part ThereofDecember 2022December 2023Allow1211YesNo
18066721SYSTEMS AND METHODS FOR AN ULTRASONICALLY DRIVEN ANESTHETIC VAPORIZERDecember 2022December 2024Allow2400YesNo
17984372Biometric and Environmental Monitoring and Control SystemNovember 2022February 2025Allow2710NoNo
17975708CPAP FLOW DRIVER FOR USING NEBULIZER WITH CPAP APPARATUSOctober 2022December 2024Abandon2611NoNo
17965037TEXTILE SEAL WITH AIR-ASSISTED BIASING PORTIONOctober 2022March 2024Allow1700NoNo
17929538INTRANASAL COMPOSITION OF PHARMACEUTICAL COUNTERMEASURES FOR CHEMICAL WARFARE NERVE AGENTS AND ACCIDENTAL EXPOSURE TO ORGANOPHOSPHATE PESTICIDESSeptember 2022June 2024Allow2210NoNo
17802403PORTABLE VENTILATORAugust 2022May 2025Allow3300YesNo
17887430SYSTEMS FOR INHALATION OF THERAPEUTIC AND DIAGNOSTIC GAS AND METHODS OF USE THEREOFAugust 2022February 2024Allow1810YesNo
17869380METHODS FOR MEASURING DOSE CONTENT UNIFORMITY PERFORMANCE OF INHALER AND NASAL DEVICESJuly 2022November 2023Allow1610NoNo
17863527Medical TubeJuly 2022April 2024Abandon2130NoNo
17858704SEAL FOR A PATIENT INTERFACE, INTERFACE ASSEMBLIES AND ASPECTS THEREOFJuly 2022January 2025Allow3120NoNo
17857686AEROSOL GENERATING SYSTEM WITH PREVENTION OF CONDENSATE LEAKAGEJuly 2022September 2023Allow1410NoNo
17857862METHODS AND APPARATUS FOR HIGH GAS FLOWJuly 2022February 2024Allow1920YesNo
17849223SMART VALVED HOLDING CHAMBERJune 2022August 2023Allow1410YesNo
17847968Inhalers and Related MethodsJune 2022August 2023Allow1410YesNo
17831634FILTERING FACEPIECE RESPIRATORJune 2022February 2023Allow911YesNo
17746251MEASUREMENT DEVICE AND METHOD FOR MONITORING CONDITION OF PATIENTMay 2022December 2022Allow711YesNo
17725396FacemaskApril 2022January 2023Abandon910NoNo
17695544VAPORIZABLE SUBSTANCE STORAGE DEVICEMarch 2022October 2024Abandon3130YesNo
17641751ORO-NASAL PATIENT INTERFACEMarch 2022October 2023Allow2020YesNo
17665902DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERYFebruary 2022December 2023Allow2220YesNo
17568277SWIVEL ELBOW AND CONNECTOR ASSEMBLY FOR PATIENT INTERFACE SYSTEMSJanuary 2022December 2022Allow1120YesNo
17559850PATIENT INTERFACE WITH FOAM SEAL-FORMING STRUCTUREDecember 2021October 2024Allow3410YesNo
17558296CONTROL OF FLOW AND/OR PRESSURE PROVIDED BY BREATHING APPARATUSDecember 2021March 2024Allow2720YesNo
17551607Biometric and environmental monitoring and control systemDecember 2021July 2023Allow1910NoNo
17453111INHALANT DISPENSING SYSTEM AND APPARATUSNovember 2021September 2024Abandon3501NoNo
17451239PRESSURIZING MASKS, SYSTEMS AND METHODSOctober 2021June 2024Allow3230NoNo
17599401COLLAPSIBLE, DISPOSABLE MEDICATION INHALATION SPACER AND METHODSeptember 2021January 2023Allow1511YesNo
17471931PHARYNGEAL RESPIRATORSSeptember 2021February 2022Allow500YesNo
17430163TEXTILE SEAL WITH AIR-ASSISTED BIASING PORTIONAugust 2021June 2022Allow1010YesNo
17396588COMPACT PORTABLE OXYGEN CONCENTRATORAugust 2021June 2025Allow4730YesNo
17394969METHOD AND APPARATUS FOR ORAL FLOW THERAPYAugust 2021July 2024Abandon3610NoNo
17371756Floatable Breathing DeviceJuly 2021April 2025Allow4500YesNo
17368891NASAL MASK SYSTEMJuly 2021May 2025Abandon4731YesNo
17356830Venturi Inhalation DeviceJune 2021September 2023Allow2721YesNo
17354980MASK/RESPIRATOR WITH MICROPHONEJune 2021August 2022Abandon1411YesNo
17311164LARGE DOSE DISPOSABLE INHALER AND METHOD OF SIMPLE FILLINGJune 2021January 2025Allow4320NoNo
17337051Dental Aerosol Protection SystemJune 2021March 2025Allow4600YesNo
17333338METHOD OF OPERATING A NASAL DRUG DELIVERY DEVICEMay 2021June 2023Allow2410NoNo
17333694AEROSOL DELIVERY SYSTEM AND METHODMay 2021October 2023Allow2920NoNo
17324448OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICEMay 2021April 2023Allow2310YesNo
17292033TRACHEOSTOMY VALVE COMPRISING A FLEXIBLE MEMBRANEMay 2021June 2025Allow4930YesNo
17243335MASK WITH ONE OR MORE SELF-SEALING PORTS AND SURGICAL KITS AND SYSTEMS ASSOCIATED THEREWITHApril 2021June 2024Allow3810YesNo
17285552BREATH ACTUATED INHALERSApril 2021February 2024Allow3410NoNo
17205280VENTING OF PHARMACEUTICAL DRUG DELIVERY DEVICE FOR AIR FLOW AND HUMIDITY CONTROLMarch 2021December 2023Allow3301YesNo
17276958DEVICE FOR NASAL DELIVERY OF FLUID PRODUCTMarch 2021May 2025Abandon5021NoNo
17199039MEDICAL TUBE HOLDER SYSTEM AND RELATED METHODSMarch 2021April 2024Abandon3710NoNo
17194429PATIENT INTERFACE COMPONENTMarch 2021September 2023Allow3100YesNo
17194369END-OF-DOSE DETECTION IN NEBULIZERSMarch 2021January 2024Allow3530YesNo
17188846FILTERING FACEPIECE RESPIRATORMarch 2021March 2022Allow1221YesNo
17163699PATIENT AIRWAY DOME AND METHODS OF MAKING AND USING SAMEFebruary 2021July 2021Allow610YesNo
17142647PATIENT INTERFACE AND ASPECTS THEREOFJanuary 2021October 2023Allow3320NoNo
17115900Floatable Breathing DeviceDecember 2020June 2023Allow3010YesNo
17115881Twist-Lock InhalerDecember 2020November 2023Abandon3510NoNo
17108156METERED DOSE INHALER AND SPACER WITH AIRFLOW AND HANDICAP ASSIST STRUCTURES FOR MAXIMIZING MEDICATION DELIVERY EFFECTIVENESSDecember 2020September 2022Abandon2120NoNo
17102033METHODS AND APPARATUS TO DELIVER THERAPEUTIC NON-ULTRAVIOLET ELECTROMAGNETIC RADIATION FOR AN ENDOTRACHEAL TUBENovember 2020December 2023Abandon3720NoNo
17087510BREATHING CIRCUIT SYSTEMS AND DEVICESNovember 2020September 2023Allow3510YesNo
17069912SYSTEM AND METHOD FOR CONTROLLING AND MONITORING FLOW IN AN ENDOTRACHEAL TUBEOctober 2020October 2023Allow3611NoNo
17068387Collapsible Spacer for Metered-Dose InhalersOctober 2020August 2023Allow3420NoNo
17010534MEDICAL DEVICE WITH ENERGY HARVESTING SYSTEMSeptember 2020October 2023Allow3811NoNo
17001450MINIATURE AIR FILTRATION ASSEMBLY FOR A MEDICAL FIELDAugust 2020November 2021Allow1411YesNo
16991677PEDIATRIC RESPIRATORY THERAPY INHALER APPARATUSAugust 2020July 2023Allow3510NoNo
16987573Biometric and Environmental Monitoring and Control SystemAugust 2020January 2023Allow3000YesNo
16945801VAPORIZERJuly 2020May 2024Abandon4620NoNo
16965141BREATHABLE GAS AND WATER HOSE APPARATUSJuly 2020June 2025Abandon5930NoNo
16931750MOUTHPIECE WITH AN ENHANCED SPRAYING EFFECT, AND PORTABLE NEBULIZER THEREOFJuly 2020August 2023Abandon3710NoNo
16930486PRESSURE AND OXYGEN MIX CONTROL FOR SINGLE LIMB NON-INVASIVE VENTILATIONJuly 2020November 2023Allow4010NoNo
16927639SECURE ELECTRONIC VAPORIZER AND NEBULIZER SYSTEMSJuly 2020June 2023Allow3510NoNo
16924071APPARATUS FOR SUPPLYING GASES TO A PATIENTJuly 2020April 2023Allow3310YesNo
16924067DRY POWDER DRUG DELIVERY SYSTEM AND METHODSJuly 2020November 2022Allow2910NoNo
16958056NASAL DRUG DELIVERY DEVICESJune 2020February 2021Allow801YesNo
16956870ENDOTRACHEAL TUBE GUARD WITH OPTIONAL HOLDING SYSTEM AND OPTIONAL SENSORJune 2020January 2023Allow3000YesNo
16906390NEBULIZER DEVICEJune 2020January 2023Abandon3110NoNo
16902092PROTECTIVE SHIELD SYSTEMJune 2020May 2021Allow1120YesNo
16899731PATIENT AIRWAY DOME AND METHODS OF MAKING AND USING SAMEJune 2020November 2020Allow510YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RUDDIE, ELLIOT S.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
5
Examiner Affirmed
2
(40.0%)
Examiner Reversed
3
(60.0%)
Reversal Percentile
84.0%
Higher than average

What This Means

With a 60.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
12
Allowed After Appeal Filing
5
(41.7%)
Not Allowed After Appeal Filing
7
(58.3%)
Filing Benefit Percentile
67.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 41.7% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner RUDDIE, ELLIOT S - Prosecution Strategy Guide

Executive Summary

Examiner RUDDIE, ELLIOT S works in Art Unit 3785 and has examined 305 patent applications in our dataset. With an allowance rate of 71.8%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 36 months.

Allowance Patterns

Examiner RUDDIE, ELLIOT S's allowance rate of 71.8% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by RUDDIE, ELLIOT S receive 1.97 office actions before reaching final disposition. This places the examiner in the 64% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by RUDDIE, ELLIOT S is 36 months. This places the examiner in the 18% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +45.1% benefit to allowance rate for applications examined by RUDDIE, ELLIOT S. This interview benefit is in the 92% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.0% of applications are subsequently allowed. This success rate is in the 40% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 33.3% of cases where such amendments are filed. This entry rate is in the 42% percentile among all examiners. Strategic Recommendation: This examiner shows below-average receptiveness to after-final amendments. You may need to file an RCE or appeal rather than relying on after-final amendment entry.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 44% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 64.3% of appeals filed. This is in the 39% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.

Petition Practice

When applicants file petitions regarding this examiner's actions, 17.1% are granted (fully or in part). This grant rate is in the 9% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 43% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.